NCT03072030View on ClinicalTrials.gov

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

PHASE4CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 3, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

July 31, 2020

Conditions
Ebola Virus DiseasePrevention
Interventions
BIOLOGICAL

GamEvac-Combi (vaccine)

vaccination

BIOLOGICAL

Placebo

vaccination

Trial Locations (2)

Unknown

Centre de recherche en épidémiologie, microbiologie et de soins médicaux (CREMS) de Pastoria à Kindia, Kindia

Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow

All Listed Sponsors
collaborator

CREMS (Centre de Recherche Epidémiologie, Microbiologie et Soins médicaux )

UNKNOWN

lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER

NCT03072030 - International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi | Biotech Hunter | Biotech Hunter